Innovation

By targeting unique biological mechanisms and/or employing novel formulations, Redwood Pharma’s dry eye therapies RP101 and RP501 offer new therapeutic solutions to patients.


Potential

As the causes of dry eye disease are varied, Redwood Pharma’s therapeutic solutions can address large unmet medical needs in a broad spectrum of applications, as well as in the largest patient population. 


Technology
Products
About us
Investor relations